The abstract is read at the publisher; the summary is JClub's.
A HIF-1α–CKB feedforward loop in profibrotic kidney macrophages sustains HIF-1α signaling and drives fibrosis, and disrupting it halts disease in mouse CKD models.
- Why it matters: Chronic kidney disease therapies often cannot reverse established fibrosis, and the mechanisms that make fibrosis self-perpetuating and progressive were unclear.
- What they did: eSphk1-deficient mice were tested with angiotensin-II infusion, unilateral ureteral obstruction, or ischemia reperfusion; macrophage metabolomics and [13C6 15N4]-arginine fluxomics assessed arginine–creatine rewiring, while HIF-1α inhibition or macrophage Ckb knockdown tested causality.
- The result: In mice, pharmacologic HIF-1α inhibition or macrophage Ckb knockdown collapsed the autonomous loop and halted fibrosis; in 131 CKD patients, CKB mRNA in peripheral blood mononuclear cells rose with estimated glomerular filtration rate decline and histologic fibrosis score.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.